News Release

Blackhawk Growth Files Quarter Ended September 30, 2021 Financials and Reports Increase in Value of its Portfolio by 165% Quarter Over Quarter

By November 29, 2021 No Comments

Blackhawk Growth Corp.

 

Vancouver, British Columbia – TheNewswire – November 29, 2021 – Blackhawk Growth Corp. (CSE:BLR); (CNSX:BLR.CN); (OTC:BLRZF); (Frankfurt:0JJ) (the “Company”), is pleased to announce that the financial statements and MD&A for its first quarter ended September 30, 2021 have been filed on Sedar.

Highlights for the quarter ended September 30, 2021:

  • Blackhawk acquires MindBio Therapeutics Pyt Ltd., clinical stage drug development company that is pioneering psychedelic micro-dosing research and is advancing emerging therapies to treat a range of debilitating health conditions such as depression, anxiety, chronic pain, cognitive impairment and PTSD. 

  • Spaced Food Inc. begins commercial production of it proprietary Astronaut Sorbet 

  • Sac Pharma Partners Inc. continues to record record results and launches new proprietary strains 

  • As at September 30, 2021, Blackhawk held $16,719,850 in current investments, a 165% increase from the value at June 30, 2021 

  • As at September 30, 2021, NAV per share was $0.38 

 

Blackhawk Growth Corp. (“Blackhawk” or the “Company”) continues to review both equity and debt investment opportunities. The Company has focused its investments in the health, cannabis and CBD industries, in both Canada and the US.

 

“Our acquisition of MindBio Therapeutics in the first quarter ending September 30, 2021 was a transformational step forward for Blackhawk. Our portfolio of companies continue to show growth and value to our shareholders as we work to execute, expand and deliver even more value to shareholders over the course of the year” says Frederick Pels, CEO of Blackhawk Growth Corp.  

As at September 30, 2021 the Company’s equity investments consist of the following:

 

Company

Cost

Fair Value

SAC Pharma Partners Inc.

$        1,890,000

$        1,890,000

Noble Line Inc.

        986,800

        986,800

Trip Pharma

997,644

997,644

NuWave Foods Inc.

783,892

783,892

Gaia Grow Corp.

1,050,000

900,000

Engine Media (UMG)

41,043

10,244

Fantasy Aces Daily Fantasy Sports Corp.

455,268

13,441

Spaced Food Inc.

311,191

311,191

MindBio Therapeutics

10,826,638

10,826,638

Total Equity Investments

$        17,342,476

$        16,719,850

 

Short-term loans consist of the following:

 

 

September 30, 2021

June 30, 2021

Short term loans

259,609

259,609

Total loan investments

$        259,609

$        259,609

  

About Blackhawk Growth

 

Blackhawk Growth is an investment holding looking to create substantial value for its shareholders through the acquisition and development of high growth companies. It has focused its investments in the health, cannabis and cannabidiol industries in both Canada and the United States. Its portfolio of companies includes Sac Pharma, LeichtMind Clinics, Noble Hemp, Spaced Food and NuWave Foods. Blackhawk continues to bring its investments to cash flow and is growing at an exceeding pace.

The company diligently posts updates through videos from the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A  

 

Please join the conversation on our Blackhawk group supporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com.

 

For more information on Blackhawk, please visit our website at:

https://www.blackhawkgrowth.com/

Frederick Pels, Chief Executive Officer

(403)-991-7737

[email protected]blackhawkgrowth.com

Cautionary Note Regarding Forward-Looking Statement

 

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the future prospects of the business of the Company and its portfolio companies. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.